Computerized Chest Imaging in the Diagnosis and Assessment of the Patient with Chronic Obstructive Pulmonary Disease - 13/08/20
, George R. Washko, MD, MScRésumé |
Computerized tomography in chronic obstructive pulmonary disease (COPD) has been the subject of intense interest in the research and clinical community. Methods have been developed to objectively detect and quantify processes affecting the lung parenchyma, airways and vasculature, as well as extrapulmonary manifestations of the noxious effects of chronic inhalational exposures, such as tobacco smoke. This article provides a brief overview of image-based advances in COPD research and then discusses how these advances have translated to clinical care, finishing with a brief description of a path forward for the convergence of research and care at the bedside.
Le texte complet de cet article est disponible en PDF.Keywords : Chronic obstructive pulmonary disease, Lung, Imaging, Computed tomography, Parenchyma, Vasculature, Comorbidity
Plan
| Competing interests: C.L. Pistenmaa received research grants from the Alpha-1 Foundation and Boehringer Ingelheim. G.R. Washko received research grants from Boehringer Ingelheim, BTG Interventional Medicine and Janssen Pharmaceuticals, and personal fees from Boehringer Ingelheim, PulmonX, Janssen Pharmaceuticals, GlaxoSmithKline, Novartis, and Vertex and is a cofounder and co-owner of Quantitative Imaging Solutions, a company that provides image-based consulting and develops software to enable data sharing. |
|
| Funded by: NIHHYB. Grant number(s): K23 HL141651; R01 HL116473. |
Vol 41 - N° 3
P. 375-381 - septembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
